Department of Medicine, University of California San Diego and the VA San Diego Healthcare System, La Jolla, California
Correspondence: Richard S. Kornbluth, Department of Medicine - 0679, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093.
CD40 ligand (also called CD40L, CD154, or TNFSF5) is a membrane protein expressed mainly by activated CD4+ T cells, which interacts with its receptor, CD40, on a variety of cells. The crucial importance of the CD40L-CD40 system for many immune responses has been extensively described. This review focuses on the multiple roles that this system may play in HIV infection. In early HIV infection, CD40L expression contributes to the immunological control of viral replication by inducing HIV-suppressive chemokines and supporting the production of anti-HIV antibodies and cytotoxic T cells. However, by activating antigen-presenting cells, such as dendritic cells and macrophages, CD40L can also lead to increased CD4+ T cell activation, which promotes the replication of HIV in these lymphocytes. Later, with the development of AIDS, CD40L-expressing CD4+ T cells become selectively depleted, perhaps as a result of a gp120-induced signal through CD4 that down-regulates CD40L expression. This acquired CD40L deficiency may explain the similarity between the types of opportunistic infections that occur in AIDS and in congenital CD40L deficiency. Vaccines or other strategies that promote the growth of CD4+ T cells capable of expressing CD40L may help to sustain host immunity against HIV and prevent AIDS-defining opportunistic infections.
Key Words: CD40 ligand • HIV • CD4+ T cells
This article has been cited by other articles:
 |
|
 |
|
  R. T.-Y. Wong, C.-C. Hon, F. Zeng, and F. C.-C. Leung Screening of differentially expressed transcripts in infectious bursal disease virus-induced apoptotic chicken embryonic fibroblasts by using cDNA microarrays J. Gen. Virol., June 1, 2007; 88(6): 1785 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Hodara, M. C. Velasquillo, L. M. Parodi, and L. D. Giavedoni Expression of CD154 by a Simian Immunodeficiency Virus Vector Induces Only Transitory Changes in Rhesus Macaques J. Virol., April 15, 2005; 79(8): 4679 - 4690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. V. Sipsas and P. P. Sfikakis Expanding Role of Circulating Adhesion Molecules in Assessing Prognosis and Treatment Response in Human Immunodeficiency Virus Infection Clin. Vaccine Immunol., November 1, 2004; 11(6): 996 - 1001. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Smed-Sorensen, K. Lore, L. Walther-Jallow, J. Andersson, and A.-L. Spetz HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation Blood, November 1, 2004; 104(9): 2810 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Daoussis, A. P. Andonopoulos, and S.-N. C. Liossis Targeting CD40L: a Promising Therapeutic Approach Clin. Vaccine Immunol., July 1, 2004; 11(4): 635 - 641. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chougnet Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells J. Leukoc. Biol., November 1, 2003; 74(5): 702 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Belz, D. Wodarz, G. Diaz, M. A. Nowak, and P. C. Doherty Compromised Influenza Virus-Specific CD8+-T-Cell Memory in CD4+-T-Cell-Deficient Mice J. Virol., December 1, 2002; 76(23): 12388 - 12393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. V. Sipsas, P. P. Sfikakis, A. Kontos, and T. Kordossis Levels of Soluble CD40 Ligand (CD154) in Serum Are Increased in Human Immunodeficiency Virus Type 1-Infected Patients and Correlate with CD4+ T-Cell Counts Clin. Vaccine Immunol., May 1, 2002; 9(3): 558 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Cotter, J. Zheng, M. Che, D. Niemann, Y. Liu, J. He, E. Thomas, and H. E. Gendelman Regulation of Human Immunodeficiency Virus Type 1 Infection, {beta}-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry J. Virol., May 1, 2001; 75(9): 4308 - 4320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Montaner, C.-F. Perno, and S. Crowe Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis J. Leukoc. Biol., September 1, 2000; 68(3): 301 - 302. [Full Text] [PDF]
|
|
